SCHEMBL13638369

SCHEMBL13638369

Cc1ccc(S(=O)(=O)NC(=O)Nc2ccc(-n3cnc4cc(NC5CC5)ccc4c3=O)cc2)s1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
P2RY12 Q9H244 1/20 0.37
GRM5 P41594 1/20 0.35
GRM1 Q13255 1/20 0.35
MAPK14 Q16539 4/20 0.34
ATM Q13315 1/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PPARG P37231 3/20 0.33
WEE1 P30291 1/20 0.33
CHEK1 O14757 2/20 0.33
FLT3 P36888 2/20 0.33
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922710 0.91 P2RY12 (0.45) ESR1ESR2P2RY12GRM5GRM1
SCHEMBL12177100 0.90 WEE1 (0.34) P2RY12SMN1; SMN2PPARGWEE1CHEK1
SCHEMBL14113771 0.88 ESR1 (0.36) ESR1ESR2P2RY12GRM1MAPK14
SCHEMBL12177640 0.86 ESR1 (0.39) ESR1ESR2P2RY12ATMNPC1
SCHEMBL12177232 0.85 P2RY12 (0.43) P2RY12PPARG
SCHEMBL13638647 0.85 P2RY12 (0.39) ESR1ESR2P2RY12ATMNPC1
SCHEMBL14228643 0.85 PPARG (0.41) ESR1ESR2P2RY12ATMRAB9A
SCHEMBL13638705 0.83 ATM (0.43) ATM
SCHEMBL13638370 0.83 P2RY12 (0.38) ESR1ESR2P2RY12MAPK14ATM
SCHEMBL14113551 0.83 HRH3 (0.39) P2RY12FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed
US-7358257-B2 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents PORTOLA PHARMACEUTICALS, INC. (US) 2008-04-15 US disclosed